Literature DB >> 949182

Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.

E C Ernst, S Berger, M Barza, N V Jacobus, F P Tally.   

Abstract

The activity of cefamandole was comparable to that of cephalothin, cefazolin, and cephaloridine against Staphylococcus aureus, Streptococcus pyogenes, and Diplococcus pneumoniae. In contrast, cefamandole was considerably more active than cephalothin, cefazolin, or cephaloridine against gram-negative facultative bacilli, including Haemophilus influenzae, the most striking disparities being noted with indole-positive Proteus and Enterobacter. Bacteroides fragilis was more susceptible to cefoxitin than to cefamandole or cefazolin (median minimal inhibitory concentration, approximately 8, 32, and 32 mug/ml, respectively); cephalothin exhibited still less activity against this species. The majority of other anaerobes were inhibited by relatively low concentrations of all four cephalosporins. The results indicate a potentially valuable role for cefamandole against facultative gram-negative bacilli, including H. influenzae, but no exceptional activity against anaerobes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 949182      PMCID: PMC429632          DOI: 10.1128/AAC.9.5.852

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Susceptibility of anaerobes to cefoxitin and other cephalosporins.

Authors:  F P Tally; N V Jacobus; J G Bartlett; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

2.  Letter: Sensitivity of haemophilus influenzae to cephalosporins.

Authors:  S Eykyn; I Phillips
Journal:  Br Med J       Date:  1974-04-06

3.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

4.  Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.

Authors:  V L Sutter; S M Finegold
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

5.  Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

Authors:  W E Wick; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

6.  Cefamandole: antimicrobial activity in vitro of a new cephalosporin.

Authors:  B R Meyers; B Leng; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

7.  Bactericidal activity and pharmacology of cefazolin.

Authors:  M G Bergeron; J L Brusch; M Barza; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

8.  Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

9.  Sensitivity of Haemophilus influenzae to antibiotics.

Authors:  J D Williams; J Andrews
Journal:  Br Med J       Date:  1974-01-26
  9 in total
  26 in total

1.  Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis.

Authors:  B Olsson; K Dornbusch; C E Nord
Journal:  Med Microbiol Immunol       Date:  1977-10-07       Impact factor: 3.402

2.  Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.

Authors:  M Barza; S Melethil; S Berger; E C Ernst
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

3.  Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates.

Authors:  R N Jones; P C Fuchs; T L Gavan; E H Gerlach; A L Barry; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

4.  In vitro comparison of synergism between cefamandole and gentamicin or tobramycin by the triple layer agar method with enzymatic inactivation.

Authors:  E Yourassowsky; E Schoutens; M P Van der Linden; M J Lismont
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 5.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  Growth curves, microscopic morphology, and subcultures of beta-lactamase-positive and -negative Haemophilus influenzae under the influence of ampicillin and cefamandole.

Authors:  E Yourassowsky; M P Van Der Linden; M J Lismont
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

7.  Comparative in vitro activity of newer cephalosporins against anaerobic bacteria.

Authors:  A W Chow; D Bednorz
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

8.  Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis.

Authors:  P L Goldman; D T Durack; R G Petersdorf
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

9.  Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics.

Authors:  V P Syriopoulou; D W Scheifele; C M Sack; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

10.  Anaerobic bacteria: evaluation of disc susceptibility to four cephalosporins.

Authors:  J Dubois; J C Pechère
Journal:  Infection       Date:  1978       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.